Norwich Eaton Pharmaceuticals

Norwich Eaton Pharmaceuticals was a prominent American pharmaceutical company based in Norwich, New York, with a history dating back to the founding of the Norwich Pharmacal Company in 1887. The company was well-regarded for its expertise in developing specialty small molecule therapeutics, particularly in the fields of anti-infectives, urology, and musculoskeletal health. Key products in its commercial portfolio included Macrodantin for urinary tract infections and Dantrium, a critical treatment for malignant hyperthermia. In 1982, the company was acquired by Procter & Gamble for approximately $371 million, serving as the cornerstone for P&G's expansion into the ethical pharmaceutical market. Its legacy assets eventually transitioned through various owners, including Warner Chilcott and later Actavis and Teva.